jc
jc

News Center

Check category
/
/
/
China's new generation of interventional heart valves are allowed to register

China's new generation of interventional heart valves are allowed to register

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-05-05 14:41
  • Views:

(Summary description)

China's new generation of interventional heart valves are allowed to register

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-05-05 14:41
  • Views:
Information

  Suzhou Jincheng Medical Technology Co., Ltd. independently developed the "J-Valve involved in artificial biological heart valve" by the State Food and Drug Administration approved the listing. This is China's first original and has a leading international intellectual property involved in heart valves, is currently the world's only effective minimally invasive treatment of aortic valve insufficiency or stenosis of the product.

 

X

 

  J-Valve heart valve can be based on cardiac anatomical structure automatically precise positioning, minimally invasive catheter intervention method to replace the aortic disease valve. The original positioning device cleverly solved the valve precision implantation and stable anchoring of these troubled minimally invasive heart valve field for many years the key link, to overcome the interventional valve can not effectively treat aortic valve insufficiency of the world problem. This technique avoids the shortcomings of traditional thoracotomy and conventional interventional valve replacement, which makes the operation time is short, the trauma is small, the postoperative recovery is quick and the complication is less, which provides effective treatment for the elderly and high risk patients.

 

X

 

  J-Valve heart valve is the State Food and Drug Administration's "innovative medical equipment special approval procedures (Trial)" innovative special approval project. The core technology of the product by the "National Thousand Program" invited experts and a number of international senior professionals based on years of experience in research and development. Advanced design concepts and significant clinical effects aroused the international heart of the academic community, J-Valve clinical research results in the cardiovascular field of the most influential magazine JACC and other international authoritative journals have published, J-Valve clinical experts are also frequently invited To the field of catheter cardiovascular treatment of the largest annual TCT and other large international academic conference speech.


   
  J-Valve technology is also China's first successful development of Western developed countries, high-end medical technology. February 2016, St. Paul's Hospital in Canada, the use of J-Valve successfully treated a no other treatment regimens of patients with severe aortic valve disease, the Chinese Consul General in Vancouver Liu Fei heard in the media interview publicly pointed out that "this is China's independent intellectual property rights For the first time into the developed countries, carried out a very broad field of cooperation. "


   
  Today, J-Valve heart valve in the application for registration after less than 1 year time will be the State Food and Drug Administration approval of the listing, which fully reflects the country to encourage innovation, promote the implementation of medical equipment localization policy.

 

X

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息